Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Controlled Trial on the Use of EPO to Reduce Top-up Transfusions in Neonates With Red Blood Cell Alloimmunization Treated With Intrauterine Transfusions

NCT03104426 is registered in ClinicalTrials.gov with Sanquin-LUMC J.J van Rood Center for Clinical Transfusion Research as lead sponsor.

NCT NCT03104426
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03104426 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Controlled Trial on the Use of EPO to Reduce Top-up Transfusions in Neonates With Red Blood Cell Alloimmunization Treated With Intrauterine Transfusions
Lead sponsor
Sanquin-LUMC J.J van Rood Center for Clinical Transfusion Research
Phase
Phase 2/3
Overall status
Unknown status
Start date
October 31, 2017
Completion date
August 31, 2020
Enrollment
42 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

erythroblastosis fetalis due to isoimmunization, erythroblastosis fetalis due to rh antibodies, erythroblastosis fetalis, rh disease, erythroblastosis, fetal